Copy
View this email in your browser
CBD is everywhere,
but scientists still don’t know much about it
 
Cannabidiol (CBD) is one of roughly 100 chemicals contained in marijuana called cannabinoids, meaning they are unique to the cannabis plant (which contains several hundred more chemicals in addition to cannabinoids). Unlike THC, the psychoactive marijuana component primarily responsible for producing the “high,” CBD is not psychoactive.
 
Manufacturers tout CBD as a magic bullet that cures or relieves symptoms of a multitude of diseases and conditions and as a “wellness” product that improves health. Hundreds of CBD products -- oils, salves, sprays, tinctures, even gummies – are available. But little science supports CBD’s medical claims.
 
“It is a kind of a new snake oil in the sense that there are a lot of claims and not so much evidence,” says Dustin Lee, an assistant professor in psychiatry and behavioral sciences at Johns Hopkins University. He is planning a clinical trial to see if CBD can help smokers quit.
 
Last summer. the FDA approved Epidiolex, the only form of pharmaceutical CBD that has met FDA standards of safety and efficacy, to treat two rare forms of epilepsy. Because CBD is a drug, it cannot be sold in food or drinks, and several states and cities have ordered restaurants to stop adding it to “lattes, smoothies, muffins, and other foods.”
 
That hasn’t stopped producers from selling CBD gummies, lollipops, and peanut butter, however. Google “CBD,” click on “Images,” and scroll sideways to “edibles” to see the wide array of commercial food products available.
 
Dr. Yasmin Hurd, who directs the Addiction Institute at Mount Sinai and is professor at the Icahn School of Medicine, has studied CBD extensively. She says there is potential for CBD to reduce heroin cravings in those recovering from addiction. But “let’s do the research,” she says. “It’s crazy that this substance is being consumed by everybody, yet we still don’t know the mechanism of action.”
 
Dr. Lee adds that procuring high quality, uncontaminated CBD for research remains a daunting task. “It might be available at the local 7-11 in Pennsylvania, but any product you get on the market is not federally regulated by the FDA, so the purity and safety and quality are questionable.”
 
A recent study of CBD products ordered online found that nearly 70 percent were inaccurately labeled and contained either higher or lower amounts of CBD than indicated on the label.
 
Says Dr. Hurd, “People are making it out to be a nirvana kind of drug, and that’s a problem. One compound cannot cure everything.”
 
Read the New York Times article here.

 
Limited access marijuana laws for medical use
 
Here is a table compiled by the Robert Wood Johnson Foundation’s Network for Public Health Law that lists the states that have legalized limited access to CBD oils and the amounts of THC they permit them to contain.
 
CBD can be extracted from both marijuana and hemp. Hemp is the marijuana plant but contains only a minute amount of THC (0.3% -- three-tenths of one percent). Any amount of THC over 0.3% is marijuana.
 
Access Table here.
 

The Marijuana Report is a weekly e-newsletter published by National Families in Action in partnership with SAM (Smart Approaches to Marijuana).

Visit National Families in Action's website, The Marijuana Report.Org, to learn more about the marijuana story unfolding across the nation.

Subscribe to The Marijuana Report e-newsletter.


The Marijuana Report Staff
Executive Editor
Sue Rusche
Editor
Nicole Carter
IT Consultant
Lee Clontz
Social Media Coordinator
Margarita Eberline
 
We are grateful to our Board of Directors and Senior Adviser for their support of National Families in Action, which produces The Marijuana Report website and e-newsletter.
 
National Families in Action
Board of Directors

William F. Carter, Chairman of the Board
Realtor Berkshire Hathaway HomeServices – Georgia Properties, Atlanta.

Sue Rusche, President and CEO, Atlanta.

Richard L. Brown, Secretary
Attorney (Ret.), Lakewood Ranch, Florida
Founder & Chairman, Sudden Cardiac Arrest Association 

Jeannine F. Adams, Director
President and CEO, J. Addams & Partners, Atlanta.

Jack L. Arbiser, MD, PhD, Director
Thomas J. Lawley Professor of Dermatology
Winship Cancer Institute, Emory University, Atlanta

William H. Avery, Director
Partner (Ret.), Alston & Bird, LLP, Atlanta.

Margarita Eberline, Director
Strategy Director, 360 Marketing Plus, Atlanta.

Robert Margolis, PhD, Director
Founder, Caron Solutions Intensive Outpatient Program, Roswell, Georgia.

Shannon Murphy, MD FAAP, Director
Birmingham, Alabama 
 
Senior Adviser
Kent “Oz” Nelson, Chairman and CEO (Ret.)
United Parcel Service, Atlanta.
 
National Families
National Families
National Families
The MJ Report
The MJ Report
The MJ Report
SAM
SAM
SAM

Note: If someone forwarded this to you, please do not unsubscribe. Clicking the Unsubscribe button will end that person's subscription. Instead, please ask the person who forwarded this to you to take you off his or her forwarding list. Thank you!
Copyright © 2019 National Families in Action, All rights reserved.


unsubscribe from this list    update subscription preferences